Travere Therapeutics, Inc. 4

Timothy Coughlin exercised options for 10,000 Travere Therapeutics shares at $26.52 and sold 10,000 common shares at an average of about $50.07, ending with 56,250 shares owned.

On June 12, 2026, reporting person Timothy Coughlin exercised a stock option for 10,000 shares of Travere Therapeutics, Inc. common stock at an exercise price of $26.52 per share, acquiring the shares and increasing his direct holdings to 66,250 shares immediately post-exercise. On the same day, pursuant to a Rule 10b5-1(c) trading plan adopted on November 19, 2025, he sold 10,000 shares of common stock at a weighted average price of $50.0747 per share (range $50.00–$50.32), generating proceeds of approximately $500,747 and reducing his direct holdings to 56,250 shares. The option was fully vested and exercisable, and following these transactions Coughlin retains a significant equity position in the company.

Filing Facts

CIK

1438533

Ticker

TVTX

Form

4

Source Type

sec

Accession

0001376043-26-000010

Alert Tier

6